Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection
<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...
Váldodahkkit: | Humphreys, I, Isla S. Humphreys |
---|---|
Eará dahkkit: | Barnes, E |
Materiálatiipa: | Oahppočájánas |
Giella: | English |
Almmustuhtton: |
2011
|
Fáttát: |
Geahča maid
-
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
Dahkki: Hennig, B, et al.
Almmustuhtton: (2008) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
Dahkki: Antrobus, R
Almmustuhtton: (2014) -
Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
Dahkki: Gupta, P
Almmustuhtton: (2014) -
Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
Dahkki: Kelly, C
Almmustuhtton: (2013) -
Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
Dahkki: Northfield, J
Almmustuhtton: (2008)